MODELING ALLOXAN OSTEOPATHY IN RATS WITH CLINICAL, BEHAVIORAL, AND METABOLIC MANIFESTATIONS OF EXPERIMENTAL DIABETES
PDF

Keywords

Alloxan, diabetic osteopathy, hyperglycemia, body weight, behavioral tests, experimental model.

Abstract

The results of an experimental model of alloxan-induced osteopathy in white rats are presented. A comprehensive assessment of body weight dynamics, glycemic levels, clinical status, and behavioral responses was conducted over 28 days after alloxan administration. The development of persistent hyperglycemia, polyuria, weight loss, and signs of general exhaustion, accompanied by decreased motor activity and anxiety, was observed. The data obtained confirm the reproducibility of the alloxan-induced diabetes model and its suitability for subsequent morphological and biochemical studies of bone disorders.

PDF

References

1. Bansal S., Gupta R., Singh R. Alloxan-induced diabetes and bone health: a comparative study on biochemical and behavioral parameters in rats. J Exp Biol Med. 2020;245(3):155–162.

2. Larionov A.V., Sapronov N.S., Kudryavtseva I.V. Modeling diabetes mellitus in laboratory animals: possibilities and limitations. Bulletin of Experimental Biology and Medicine. 2021;171(8):94–99.

3. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216–226.

4. Kiseleva E.M., Nefedov V.Yu. Experimental models of diabetic osteopathy. Morphology. 2019;155(6):42–48.

5. Cersosimo E., Triplitt C. Pathophysiology of type 1 diabetes and related complications. Diabetes Care. 2022;45(Suppl 1):S31–S43.